Viking Global Opportunities Illiquid Investments Sub-Master LP

CIK 1629482 · last filed 2024-06-18

Viking Global Opportunities Illiquid Investments Sub-Master LP is a corporate insider who has filed 13 SEC Form 4 insider transactions across 11 companies since 2016. The most recent filing shows the insider sold $595.7M of APG on Jun 18, 2024. Across all open-market trades the lifetime net is +$249.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.09B across reported positions. The firm reports its address in Stamford, CT. 78 SEC filings were submitted jointly with OLE ANDREAS HALVORSEN.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.09B

Companies

11

Total Filings

13

Lifetime Open-Market Net

$249.37M

Filer Profile

Reported Address
600 WASHINGTON BLVD.
FLOOR 11
STAMFORD, CT 06901
Phone
(212) 672-7000
State of Incorporation
Cayman Islands
Related Filers
OLE ANDREAS HALVORSEN — 78 joint filings, latest 2025-10-09
David C. Ott — 78 joint filings, latest 2025-10-09
VIKING GLOBAL INVESTORS LP — 78 joint filings, latest 2025-10-09
Viking Global Opportunities GP LLC — 78 joint filings, latest 2025-10-09
Viking Global Opportunities Portfolio GP LLC — 78 joint filings, latest 2025-10-09
Rose Sharon Shabet — 71 joint filings, latest 2025-10-09
Viking Global Opportunities Parent GP LLC — 27 joint filings, latest 2025-10-09
BridgeBio Pharma, Inc. — 6 joint filings, latest 2025-07-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
APG 10%+ Owner 0 $37.86 $0 -$595.68M 1 2024-06-18
FDMT 10%+ Owner 4,787,914 $13.17 $63.06M $108.80M 1 2023-05-11
INBX 10%+ Owner 333,333 $109.27 $36.42M $320.00M 1 2022-10-12
Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted 10%+ Owner 51,055,144 $0.01 $321.6K $0 1 2022-03-04
AMLX 10%+ Owner 4,870,536 $31.62 $154.01M $349.60M 1 2022-01-13
ZNTL 10%+ Owner 3,943,284 $3.51 $13.84M -$176.75M 1 2020-12-03
ADPT 10%+ Owner 33,493,708 $24.20 $810.55M -$858.94M 1 2020-01-30
Myovant Sciences Ltd. (MYOV) Delisted 10%+ Owner 40,765,599 $26.98 $1.10B $140.00M 1 2019-06-13
Urovant Sciences Ltd. (UROV) Delisted 10%+ Owner 22,740,305 $16.24 $369.30M $962.34M 2 2019-05-23
ABUS 10%+ Owner $5.12 $0 1 2017-10-17
EDIT 10%+ Owner 2,744,880 $2.70 $7.41M $0 1 2016-02-08

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-06-18 APG Sell (S) −15,614,256 -$595.68M EDGAR
2023-07-18 BBIO Notice (144) −1,500,000 -$48.06M EDGAR
2023-05-11 FDMT Buy (P) +6,800,000 $108.80M EDGAR
2022-10-12 INBX Buy (P) +10,666,664 $320.00M EDGAR
2022-03-04 Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Other (J) −2,304,000,000 $0 EDGAR
2022-01-13 AMLX Mixed +57,364,288 $349.60M EDGAR
2020-12-03 ZNTL Sell (S) −3,500,000 -$176.75M EDGAR
2020-01-30 ADPT Sell (S) −34,390,293 -$858.94M EDGAR
2019-06-13 Myovant Sciences Ltd. (MYOV) Delisted Buy (P) +16,969,694 $140.00M EDGAR
2019-05-23 Urovant Sciences Ltd. (UROV) Delisted Buy (P) +138,810 $699.84M EDGAR
Showing 110 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.